Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Veracyte, Inc. VCYT | ARK Investment Management LLC | 9,027,827 15.590% | 2,009,057 (+28.62%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Cellectis S.A. CLLS | ARK Investment Management LLC | 6,679,077 15.720% | 1,815,312 (+37.32%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | AquaBounty Technologies, Inc. AQB | ARK Investment Management LLC | 432,021 16.110% | 202,761 (+88.44%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Materialise N.V. MTLS | ARK Investment Management LLC | 8,564,081 16.350% | 2,244,402 (+35.51%) | Filing History |
| 2021-02-16 4:33 pm Sale | 2020-12-31 | 13G | Editas Medicine, Inc. EDIT | ARK Investment Management LLC | 10,125,564 16.240% | -544,860 (-5.11%) | Filing History |
| 2021-02-16 4:33 pm Sale | 2020-12-31 | 13G | Cerus Corporation CERS | ARK Investment Management LLC | 29,572,265 17.690% | -427,806 (-1.43%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | 2U, Inc. TWOU | ARK Investment Management LLC | 442,053 18.400% | 760 (+0.17%) | Filing History |
| 2021-02-16 4:33 pm Sale | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | ARK Investment Management LLC | 904,132 19.740% | -217,119 (-19.36%) | Filing History |
| 2021-02-16 4:33 pm Sale | 2020-12-31 | 13G | Compugen Ltd. CGEN | ARK Investment Management LLC | 17,083,306 20.620% | -588,922 (-3.33%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Iridium Communications Inc. IRDM | ARK Investment Management LLC | 6,970,230 5.230% | 6,970,230 (New Position) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Stratasys Ltd. SSYS | ARK Investment Management LLC | 12,087,661 21.930% | 17,276 (+0.14%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Teladoc Health, Inc. TDOC | ARK Investment Management LLC | 7,832,332 5.400% | 7,832,332 (New Position) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Codexis, Inc. CDXS | ARK Investment Management LLC | 3,962,106 6.240% | 3,962,106 (New Position) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Surface Oncology, Inc. SURF | ARK Investment Management LLC | 2,542,391 6.250% | 2,542,391 (New Position) | Filing History |
| 2021-02-10 4:37 pm Purchase | 2021-01-31 | 13G | Castle Biosciences, Inc. CSTL | ARK Investment Management LLC | 2,552,497 10.440% | 2,552,497 (New Position) | Filing History |
| 2021-02-10 4:36 pm Purchase | 2021-01-31 | 13G | CareDx, Inc CDNA | ARK Investment Management LLC | 5,192,563 10.540% | 5,192,563 (New Position) | Filing History |